The effect of CD40 agonist antibody therapy on the pancreatic cancer microenvironment
Crossref DOI link: https://doi.org/10.1007/s00210-025-04532-x
Published Online: 2025-09-10
Published Print: 2026-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ma, Yilan
Ding, Jin
Chen, Yanping https://orcid.org/0009-0001-3165-5304
Text and Data Mining valid from 2025-09-10
Version of Record valid from 2025-09-10
Article History
Received: 29 April 2025
Accepted: 6 August 2025
First Online: 10 September 2025
Declarations
:
: It is not applicable.
: The authors declare no competing interests.